Eisai (4523.T) Financial Statements

Price: $4084
Market Cap: $1.15T
Avg Volume: 1.46M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: -0.162
52W Range: $3463-7110
Website: Eisai

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Eisai .


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$800.00B$800.00B$600.00B$600.00B$400.00B$400.00B$200.00B$200.00B$0.00$0.00201620162017201720182018201920192020202020212021202220222023202320242024
Operating Expenses
Operating Income
Operating Expenses & Income$600.00B$600.00B$500.00B$500.00B$400.00B$400.00B$300.00B$300.00B$200.00B$200.00B$100.00B$100.00B$0.00$0.00201620162017201720182018201920192020202020212021202220222023202320242024
Breakdown March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Revenue $741.75B $744.40B $756.23B $645.94B $695.62B $642.83B $600.05B $539.10B $547.92B $548.47B
Cost of Revenue $155.33B $177.84B $174.83B $161.31B $175.69B $184.49B $201.25B $195.91B $194.46B $193.59B
Gross Profit $586.42B $566.57B $581.39B $484.63B $519.93B $458.34B $398.80B $343.19B $353.46B $354.87B
Gross Profit Ratio 79.06% 76.11% 76.88% 75.03% 74.74% 71.30% 66.46% 63.66% 64.51% 64.70%
Research and Development Expenses $169.02B $173.00B $171.74B $150.30B $140.12B $144.84B $139.58B $112.48B $122.31B $131.91B
General and Administrative Expenses $374.42B $358.29B $366.43B $281.40B $256.30B $228.21B $183.86B $179.68B $192.82B $194.55B
Selling and Marketing Expenses $-10.34B $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $364.08B $358.29B $366.43B $281.40B $256.30B $228.21B $183.86B $179.68B $192.82B $194.55B
Other Expenses $- $- $-10.52B $1.17B $-1.99B $-866.00M $-1.85B $-8.03B $-13.60B $80.00M
Operating Expenses $533.01B $526.53B $527.64B $432.87B $394.43B $372.19B $321.59B $284.13B $301.53B $326.53B
Cost and Expenses $688.34B $704.36B $702.48B $594.18B $570.12B $556.68B $522.84B $480.03B $495.99B $520.13B
Interest Income $10.80B $7.24B $2.40B $2.15B $4.02B $4.86B $2.56B $1.85B $2.02B $2.43B
Interest Expense $2.39B $2.27B $1.69B $1.36B $1.46B $1.56B $2.96B $3.24B $3.48B $4.89B
Depreciation and Amortization $39.40B $39.98B $38.40B $36.30B $33.70B $26.84B $26.18B $26.48B $34.06B $38.94B
EBITDA $103.11B $87.26B $94.55B $90.05B $162.94B $117.75B $105.81B $86.93B $87.99B $69.56B
EBITDA Ratio 13.90% 11.72% 12.50% 13.94% 23.42% 18.32% 17.63% 16.12% 16.06% 12.68%
Operating Income $53.41B $40.04B $53.75B $51.77B $125.50B $86.15B $77.21B $59.06B $51.94B $28.34B
Operating Income Ratio 7.20% 5.38% 7.11% 8.01% 18.04% 13.40% 12.87% 10.96% 9.48% 5.17%
Total Other Income Expenses Net $8.41B $4.97B $708.00M $-668.00M $2.56B $3.30B $-409.00M $-1.40B $-1.46B $-2.46B
Income Before Tax $61.82B $45.01B $54.46B $52.55B $128.06B $89.45B $76.80B $57.67B $50.47B $25.88B
Income Before Tax Ratio 8.33% 6.05% 7.20% 8.14% 18.41% 13.92% 12.80% 10.70% 9.21% 4.72%
Income Tax Expense $18.04B $-11.82B $8.74B $10.07B $5.60B $22.97B $22.38B $15.42B $-4.57B $-17.58B
Net Income $42.41B $55.43B $47.95B $41.94B $121.77B $63.39B $51.84B $39.36B $54.93B $43.25B
Net Income Ratio 5.72% 7.45% 6.34% 6.49% 17.50% 9.86% 8.64% 7.30% 10.03% 7.89%
EPS $147.86 $193.31 $167.27 $146.95 $425.01 $221.02 $724.71 $550.52 $768.92 $606.28
EPS Diluted $147.86 $193.30 $167.25 $146.90 $424.80 $221.02 $723.89 $549.64 $767.04 $605.48
Weighted Average Shares Outstanding 286.80M 286.76M 286.69M 286.62M 286.51M 286.80M 286.80M 286.80M 286.80M 286.80M
Weighted Average Shares Outstanding Diluted 286.80M 286.76M 286.73M 286.71M 286.65M 286.80M 286.80M 286.80M 286.80M 286.80M
SEC Filing Source Source Source Source Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$1.50T$1.50T$1.20T$1.20T$900.00B$900.00B$600.00B$600.00B$300.00B$300.00B$0.00$0.00201620162017201720182018201920192020202020212021202220222023202320242024
Equity$1.00T$1.00T$800.00B$800.00B$600.00B$600.00B$400.00B$400.00B$200.00B$200.00B$0.00$0.00201620162017201720182018201920192020202020212021202220222023202320242024
Breakdown March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Cash and Cash Equivalents $304.68B $267.35B $309.63B $248.74B $254.24B $286.43B $270.52B $186.78B $176.83B $173.34B
Short Term Investments $445.00M $540.00M $432.00M $267.00M $1.55B $7.54B $18.66B $42.88B $19.54B $28.42B
Cash and Short Term Investments $305.12B $267.89B $310.06B $249.01B $255.80B $293.98B $289.19B $229.65B $196.37B $201.76B
Net Receivables $217.21B $187.26B $207.95B $160.31B $180.02B $156.64B $151.47B $154.50B $147.66B $174.34B
Inventory $174.65B $140.42B $99.01B $85.12B $65.73B $67.89B $80.93B $82.88B $73.68B $87.64B
Other Current Assets $26.00B $26.64B $23.58B $23.91B $19.85B $43.17B $14.31B $17.13B $30.09B $10.99B
Total Current Assets $722.98B $622.20B $640.61B $518.34B $521.40B $561.68B $535.90B $484.15B $447.80B $474.72B
Property Plant Equipment Net $164.89B $166.63B $169.93B $160.93B $144.64B $105.17B $103.06B $103.57B $104.56B $133.00B
Goodwill $236.37B $208.82B $191.76B $171.78B $168.68B $172.16B $164.96B $173.97B $174.88B $183.76B
Intangible Assets $85.49B $89.23B $95.45B $108.64B $106.09B $98.14B $107.44B $112.50B $104.16B $127.63B
Goodwill and Intangible Assets $321.86B $298.05B $287.21B $280.42B $274.78B $270.30B $272.40B $286.47B $279.04B $311.38B
Long Term Investments $58.42B $73.88B $64.95B $63.38B $54.88B $45.46B $29.13B $11.58B $24.28B $13.92B
Tax Assets $100.83B $102.59B $76.62B $66.92B $66.44B $68.62B $75.26B $88.34B $91.63B $89.00B
Other Non-Current Assets $24.82B $1.00M $- $1.00M $- $20.28B $33.28B $56.64B $26.68B $31.79B
Total Non-Current Assets $670.82B $641.15B $598.71B $571.66B $540.74B $509.84B $513.12B $546.61B $526.19B $579.09B
Other Assets $- $- $- $- $- $1.00M $1.00M $- $-1.00M $-
Total Assets $1.39T $1.26T $1.24T $1.09T $1.06T $1.07T $1.05T $1.03T $973.99B $1.05T
Account Payables $23.96B $86.83B $108.06B $94.55B $76.88B $31.25B $36.38B $34.58B $27.30B $27.77B
Short Term Debt $34.24B $41.20B $- $39.98B $34.99B $48.99B $16.40B $50.00B $- $30.23B
Tax Payables $8.72B $2.22B $6.88B $2.52B $5.36B $8.17B $9.03B $5.90B $5.44B $3.88B
Deferred Revenue $- $59.88B $-9.95B $37.36B $49.60B $78.12B $76.70B $24.52B $- $19.61B
Other Current Liabilities $237.56B $168.69B $198.39B $118.96B $134.74B $207.32B $179.86B $133.21B $121.98B $147.18B
Total Current Liabilities $304.47B $298.94B $313.33B $256.02B $251.97B $295.74B $241.67B $223.69B $154.71B $209.06B
Long Term Debt $134.77B $82.49B $94.89B $50.07B $54.95B $89.91B $156.74B $163.47B $203.59B $205.85B
Deferred Revenue Non-Current $- $38.29B $40.69B $41.21B $37.92B $11.35B $15.46B $17.52B $17.61B $10.79B
Deferred Tax Liabilities Non-Current $704.00M $664.00M $483.00M $511.00M $569.00M $282.00M $496.00M $448.00M $287.00M $514.00M
Other Non-Current Liabilities $54.88B $17.98B $18.39B $14.42B $14.11B $22.27B $20.57B $23.05B $20.96B $25.54B
Total Non-Current Liabilities $190.35B $141.83B $154.45B $106.05B $107.55B $123.80B $193.26B $204.48B $242.45B $242.69B
Other Liabilities $- $- $- $- $- $- $- $- $- $-
Total Liabilities $494.82B $440.78B $467.78B $362.07B $359.51B $419.54B $434.93B $428.17B $397.16B $451.76B
Preferred Stock $- $612.93B $595.24B $596.54B $593.62B $- $- $- $- $-
Common Stock $44.99B $44.99B $44.99B $44.99B $44.99B $44.99B $44.99B $44.99B $44.99B $44.99B
Retained Earnings $526.49B $522.77B $506.58B $507.98B $505.36B $438.49B $414.97B $394.98B $394.97B $387.97B
Accumulated Other Comprehensive Income Loss $258.89B $187.03B $153.58B $106.64B $84.51B $101.73B $91.34B $102.90B $111.70B $145.06B
Other Total Stockholders Equity $45.25B $45.17B $43.67B $43.58B $43.27B $42.92B $42.29B $41.76B $22.00B $20.73B
Total Stockholders Equity $875.61B $799.96B $748.82B $703.18B $678.13B $628.12B $593.58B $584.63B $573.66B $598.75B
Total Equity $898.98B $822.57B $771.53B $727.94B $702.63B $651.98B $614.10B $602.59B $576.83B $602.06B
Total Liabilities and Stockholders Equity $1.39T $1.26T $1.24T $1.09T $1.06T $1.07T $1.05T $1.03T $973.99B $1.05T
Minority Interest $23.36B $22.61B $22.71B $24.76B $24.50B $23.86B $20.52B $17.96B $3.17B $3.31B
Total Liabilities and Total Equity $1.39T $1.26T $1.24T $1.09T $1.06T $1.07T $1.05T $1.03T $973.99B $1.05T
Total Investments $57.67B $52.46B $44.03B $43.82B $39.78B $53.01B $47.79B $54.46B $43.82B $42.34B
Total Debt $159.41B $126.11B $94.89B $89.89B $89.94B $138.90B $173.14B $213.47B $203.59B $236.08B
Net Debt $-145.27B $-141.25B $-214.74B $-158.85B $-164.31B $-147.54B $-97.38B $26.70B $26.76B $62.75B

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$150.00B$150.00B$100.00B$100.00B$50.00B$50.00B$0.00$0.00-$50.00B-$50.00B201620162017201720182018201920192020202020212021202220222023202320242024
Financing Cash Flow$0.00$0.00-$30.00B-$30.00B-$60.00B-$60.00B-$90.00B-$90.00B-$120.00B-$120.00B201620162017201720182018201920192020202020212021202220222023202320242024
Breakdown March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Net Income $61.82B $45.01B $54.46B $52.55B $128.06B $89.45B $76.80B $57.67B $50.47B $25.88B
Depreciation and Amortization $39.40B $39.98B $38.40B $36.30B $33.70B $26.84B $26.18B $26.48B $34.06B $38.94B
Deferred Income Tax $- $- $- $- $- $- $- $- $- $-
Stock Based Compensation $- $- $- $- $- $- $- $- $- $-
Change in Working Capital $-16.18B $-61.51B $34.13B $264.00M $-43.93B $4.05B $62.97B $1.51B $35.91B $18.49B
Accounts Receivables $- $37.39B $-40.14B $25.65B $-35.17B $-5.13B $7.08B $5.15B $16.49B $15.14B
Inventory $- $-36.88B $-6.34B $-13.98B $-2.37B $6.51B $2.59B $-6.71B $5.40B $3.89B
Accounts Payables $- $- $1.03B $-1.37B $335.00M $3.33B $1.87B $-363.00M $3.06B $-
Other Working Capital $-16.18B $-62.02B $79.58B $-10.03B $-6.72B $-653.00M $48.56B $-4.30B $-6.05B $-915.00M
Other Non Cash Items $-29.05B $-25.25B $-9.40B $-15.26B $-15.05B $-16.63B $-16.30B $-9.81B $-24.83B $-7.29B
Net Cash Provided by Operating Activities $55.99B $-1.77B $117.59B $73.85B $102.78B $103.71B $149.65B $75.85B $95.62B $76.02B
Investments in Property Plant and Equipment $-14.32B $-34.56B $-40.47B $-38.14B $-50.23B $-27.62B $-24.73B $-20.00B $-40.07B $-18.43B
Acquisitions Net $- $5.21B $-1.22B $-227.00M $5.83B $5.68B $-12.32B $25.80B $11.58B $-4.13B
Purchases of Investments $-6.50B $-3.70B $-3.13B $-2.65B $-2.15B $-6.21B $-41.09B $-85.70B $-43.50B $-47.09B
Sales Maturities of Investments $3.88B $10.05B $2.49B $3.75B $13.04B $18.61B $81.02B $51.60B $51.59B $43.80B
Other Investing Activities $-8.39B $281.00M $13.48B $404.00M $5.88B $1.62B $14.17B $-305.00M $13.70B $7.00B
Net Cash Used for Investing Activities $-25.32B $-22.72B $-28.85B $-36.87B $-27.62B $-7.92B $17.04B $-28.60B $-6.70B $-18.84B
Debt Repayment $33.26B $31.17B $4.87B $-82.00M $-49.00B $-35.67B $-38.61B $9.98B $-30.32B $-17.15B
Common Stock Issued $- $- $- $- $- $- $- $- $- $-
Common Stock Repurchased $- $- $- $- $- $- $- $- $- $-
Dividends Paid $-45.91B $-45.89B $-45.88B $-45.87B $-45.85B $-42.96B $-42.93B $-42.91B $-42.87B $-42.81B
Other Financing Activities $-10.06B $-9.80B $-7.96B $-9.96B $-8.68B $-552.00M $-315.00M $-2.52B $244.00M $218.00M
Net Cash Used Provided by Financing Activities $-22.72B $-24.52B $-48.97B $-55.91B $-103.53B $-79.18B $-81.85B $-35.44B $-72.94B $-59.74B
Effect of Forex Changes on Cash $29.38B $6.74B $21.12B $13.42B $-9.31B $4.78B $-1.09B $-4.37B $-9.98B $21.97B
Net Change in Cash $37.33B $-42.28B $60.89B $-5.50B $-37.68B $21.40B $83.75B $7.45B $5.99B $19.41B
Cash at End of Period $304.68B $267.35B $309.63B $248.74B $254.24B $291.92B $270.52B $186.78B $179.33B $173.34B
Cash at Beginning of Period $267.35B $309.63B $248.74B $254.24B $291.92B $270.52B $186.78B $179.33B $173.34B $153.92B
Operating Cash Flow $55.99B $-1.77B $117.59B $73.85B $102.78B $103.71B $149.65B $75.85B $95.62B $76.02B
Capital Expenditure $-24.82B $-34.56B $-40.47B $-38.14B $-50.23B $-27.62B $-24.73B $-20.00B $-40.07B $-18.43B
Free Cash Flow $31.17B $-36.33B $77.12B $35.71B $52.56B $76.09B $124.92B $55.85B $55.55B $57.60B